No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
ACR Acrux Ltd
- 0.034
- +0.002+6.25%
20min DelayTrading Dec 16 13:24 AET
12.18MMarket Cap-1.70P/E (Static)
0.035High0.034Low1.92MVolume0.034Open0.032Pre Close65.35KTurnover0.09952wk High0.99%Turnover Ratio358.29MShares0.03052wk Low-0.02EPS TTM6.59MFloat Cap3.784Historical HighLossP/E (Static)193.79MShs Float0.030Historical Low-0.02EPS LYR3.13%Amplitude--Dividend TTM3.09P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Acrux Scores Fourth FDA Approval, Nitroglycerin Ointment Moving Into Commercialisation
Acrux Ltd: FY24 R&D Tax Incentive rebate received
Acrux Ltd: Investor Webinar Information - FY24 Results
Acrux Ltd: FY24 Full Year Results - Investor Presentation
Acrux Ltd: Appendix 4E and FY24 Full Year Statutory Accounts
Acrux Secures US FDA Approval for Generic Version of Acne Medication; Shares Jump 15%
Trending AU Stocks
ASX High Dividend ASX High Dividend